Wolfgang Neuberger

Chief Executive Officer presso BIOLITEC AG

Health Technology

Consumer Services

Profilo

Wolfgang Neuberger is currently the Chairman-Management Board at biolitec AG since 1988.
He was formerly the Chief Executive Officer at biolitec AG (Jena) from 1999 to 2012.
He holds an MBA from INSEAD and a doctorate from Technische Universität Wien, which he received in 1977.

Posizioni attive di Wolfgang Neuberger

Società	Posizione	Inizio
BIOLITEC AG	Chief Executive Officer	01/01/1988

Tutte le posizioni attive di Wolfgang Neuberger

Precedenti posizioni note di Wolfgang Neuberger

Società	Posizione	Fine
biolitec AG (Jena) biolitec AG (Jena) Medical SpecialtiesHealth Technology biolitec AG Jena develops and produces diode lasers, fibre optic disposables, and photodynamic drugs. It also provides photodynamic therapy and manufactures the cancer drug Foscan. The firm operates through the Medical Technology (Meditec) and Pharmaceuticals (Pharma) segments. The Meditec segment specializes in the distribution of fibers and laser probes. The Pharma segment focuses on the production, development and sale of pharmaceutical substances. The company was founded by Karsten Komischke, Sidney Balan, Kerstin Balan, Ilse Kaus and Denise Kaus on March 17, 1999 and is headquartered in Jena, Germany.	Chief Executive Officer	-

Vedi nel dettaglio l'esperienza di Wolfgang Neuberger

Formazione di Wolfgang Neuberger

INSEAD	Masters Business Admin
Technische Universität Wien	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Wolfgang Neuberger

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
biolitec AG (Jena) biolitec AG (Jena) Medical SpecialtiesHealth Technology biolitec AG Jena develops and produces diode lasers, fibre optic disposables, and photodynamic drugs. It also provides photodynamic therapy and manufactures the cancer drug Foscan. The firm operates through the Medical Technology (Meditec) and Pharmaceuticals (Pharma) segments. The Meditec segment specializes in the distribution of fibers and laser probes. The Pharma segment focuses on the production, development and sale of pharmaceutical substances. The company was founded by Karsten Komischke, Sidney Balan, Kerstin Balan, Ilse Kaus and Denise Kaus on March 17, 1999 and is headquartered in Jena, Germany.	Health Technology
biolitec AG biolitec AG Medical SpecialtiesHealth Technology biolitec AG engages in the provision of medical laser applications and photodynamic therapy. It also provides applications in the field of phlebology, gynecology, ear-nose-throat, orthopedics, ophthalmology, and aesthetics surgery. The company was founded in 1988 and is headquartered in Vienna, Austria.	Health Technology